The Hsp90 inhibitor ganetespib overcomes EGFR-based intratumoral heterogeneity to block glioma proliferation

被引：0
|
作者：
Driscoll, James J. [1 ]
Narayanan, Nitin S. [1 ]
Jagannathan, Sajjeev [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-LB-140
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-140
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
    Proia, David A.
    Sang, Jim
    He, Suqin
    Smith, Donald L.
    Sequeira, Manuel
    Zhang, Chaohua
    Liu, Yuan
    Ye, Shuxia
    Zhou, Dan
    Blackman, Ronald K.
    Foley, Kevin P.
    Koya, Keizo
    Wada, Yumiko
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2201 - 2209
  • [32] Ganetespib, a Novel Hsp90 Inhibitor in Patients With KRAS Mutated and Wild Type, Refractory Metastatic Colorectal Cancer
    Cercek, Andrea
    Shia, Jinru
    Gollub, Marc
    Chou, Joanne F.
    Capanu, Marinela
    Raasch, Pamela
    Reidy-Lagunes, Diane
    Proia, David A.
    Vakiani, Efsevia
    Solit, David B.
    Saltz, Leonard B.
    CLINICAL COLORECTAL CANCER, 2014, 13 (04) : 207 - 212
  • [33] The HSP90 inhibitor, AT13387, overcomes resistance to crizotinib and second generation ALK inhibitors
    Courtin, A.
    Smyth, A.
    Hearn, K.
    Martins, V.
    Lewis, J.
    Thompson, N.
    Lyons, J.
    Wallis, N.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 168 - 168
  • [34] Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models
    Di, Kaijun
    Keir, Stephen T.
    Alexandru-Abrams, Daniela
    Gong, Xing
    Nguyen, Howard
    Friedman, Henry S.
    Bota, Daniela A.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 120 (03) : 473 - 481
  • [35] HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells and Inhibits Lung Cancer Stem Cells
    Gomez-Casal, Roberto
    Bhattacharya, Chitralekha
    Basse, Per
    Epperly, Michael
    Wang, Hong
    Proia, David
    Greenberger, Joel
    Socinski, Mark A.
    Levina, Vera
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S313 - S313
  • [36] Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models
    Kaijun Di
    Stephen T. Keir
    Daniela Alexandru-Abrams
    Xing Gong
    Howard Nguyen
    Henry S. Friedman
    Daniela A. Bota
    Journal of Neuro-Oncology, 2014, 120 : 473 - 481
  • [37] The HSP90 Inhibitor XL888 Overcomes BRAF Inhibitor Resistance Mediated through Diverse Mechanisms
    Paraiso, Kim H. T.
    Haarberg, H. Eirik
    Wood, Elizabeth
    Rebecca, Vito W.
    Chen, Y. Ann
    Xiang, Yun
    Ribas, Antoni
    Lo, Roger S.
    Weber, Jeffrey S.
    Sondak, Vernon K.
    John, Jobin K.
    Sarnaik, Amod A.
    Koomen, John M.
    Smalley, Keiran S. M.
    CLINICAL CANCER RESEARCH, 2012, 18 (09) : 2502 - 2514
  • [38] HSP90 inhibitor, ganetespib, enhances responses to cancer immunotherapy through increased expression of interferon response genes
    Mbofung, Rina M.
    McKenzie, Jodi A.
    Malu, Shruti
    Liu, Chengwen
    Peng, Weiyi
    Kuiatse, Isere
    Williams, Leila
    Devi, Seram
    Wang, Zhe
    Trang Tieu
    Heffernan, Tim
    Davis, Richard E.
    Amaria, Rodabe
    Hwu, Patrick
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [39] Preclinical activity of the Hsp90 inhibitor, ganetespib, in ALK-and ROS1-driven cancers.
    Proia, David A.
    Acquaviva, Jaime
    Jiang, Qin
    Xue, Liquan
    Smith, Donald
    Friedland, Julie C.
    He, Suqin
    Sang, Jim
    Morris, Stephan
    Wada, Yumiko
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] EFFECT OF HSP90 INHIBITOR ON PROLIFERATION OF LEUKEMIA CELLS AND MECHANISM OF INDUCING APOPTOSIS
    Xu, Qian
    Wei, Yanlin
    ACTA MEDICA MEDITERRANEA, 2020, 36 (05): : 2961 - 2965
12345